Oceanpine Capital leads $73m funding in US biopharma firm Immune-Onc

Oceanpine Capital leads $73m funding in US biopharma firm Immune-Onc

01 April, 2021

Immune-Onc Therapeutics Oceanpine Capital

Printed by Unregistered user on Wed, 17 Dec 2025 14:07:04 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China-focused growth equity investor Oceanpine closes DeepTech Fund at $400m

Chinese PE Oceanpine Capital hits first close of second fund at $200m

Read more from Greater China

Warburg Pincus signs deal to invest in business service provider Acclime

MetaX shares surge 700% on debut as China’s AI chip push gathers speed